Global Peptide Antibiotics Market Report - Expected to Surpass $40 Billion by 2023 - Seite 2
With the advancement in scientific knowledge and increased research globally, the peptide antibiotics segment is bound to rise. Collaborations between major pharmaceuticals giants fuelled by increased investment and support from various government and foundations have positively impacted the growth in the peptide vaccine market. It is evident that antibiotic resistance would severely impact the antibiotics market, thus the dire need for an alternative. This particular need can successfully be fulfilled by the emergence of peptide antibiotics which would rapidly become an alternative or the most possible solution in situations where the conventional antibiotics fail. Thus it could fairly be concluded that the peptide antibiotics are the new plethora of opportunities with the potential of generating immense revenue in the future.
Companies Mentioned
- AMP Therapeutics
- Eli Lilly
- GlaxoSmithKline
- Hospira
- Kasten
- Madam Therapeutics
- Novartis
- Pacgen Life Science Corporation
- Pfizer
- Phosphagenics
- Savara Pharmaceuticals
- Theravance
- Vicuron Pharmaceuticals
Key Topics Covered:
1. Peptide Antibiotics - A New Era for Antibiotics
2. Mechanism & Production of Peptide Antibiotics
3. Identification of Human Antimicrobial Peptides
4. Portrayal of Peptide Antibiotics in Cancer Treatment
5. Categorization of Anticancer Peptides
6. Approved Peptide Antibiotics
7. Market Analysis of Peptide Antibiotics
8. Market Dynamics of Antimicrobial Peptides
9. Future Perspective of Peptide Antibiotics Market & Drug Development
10. Global Peptide Antibiotics Clinical Pipeline Overview
11. Global Peptide Antibiotics Clinical Pipeline by Company, Indication & Phase
12. Marketed Peptide Antibiotics Clinical & Patent Analysis
13. Competitive Landscape
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/dtxs2h/global_peptide
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716